According to Zen Score, the 3 best medical distribution stocks to buy right now are:
1. Mckesson (NYSE:MCK)
Mckesson (NYSE:MCK) is the top medical distribution stock with a Zen Score of 54, which is 14 points higher than the medical distribution industry average of 40. It passed 21 out of 38 due diligence checks and has strong fundamentals. Mckesson has seen its stock return 49.22% over the past year, overperforming other medical distribution stocks by 18 percentage points.
Mckesson has an average 1 year
price target of $560.22, an upside of 5.93% from Mckesson's current stock price of $528.86.
Mckesson stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 9 analysts covering Mckesson, 55.56% have issued a Strong Buy rating, 22.22% have issued a Buy, 22.22% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Cardinal Health (NYSE:CAH)
Cardinal Health (NYSE:CAH) is the second best medical distribution stock with a Zen Score of 51, which is 11 points higher than the medical distribution industry average of 40. It passed 19 out of 38 due diligence checks and has strong fundamentals. Cardinal Health has seen its stock return 21.15% over the past year, underperforming other medical distribution stocks by -10 percentage points.
Cardinal Health has an average 1 year
price target of $115.00, an upside of 16.27% from Cardinal Health's current stock price of $98.91.
Cardinal Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Cardinal Health, 25% have issued a Strong Buy rating, 25% have issued a Buy, 37.5% have issued a hold, while 0% have issued a Sell rating, and 12.5% have issued a Strong Sell.
3. Cencora (NYSE:COR)
Cencora (NYSE:COR) is the third best medical distribution stock with a Zen Score of 51, which is 11 points higher than the medical distribution industry average of 40. It passed 19 out of 38 due diligence checks and has strong fundamentals. Cencora has seen its stock return 34.19% over the past year, overperforming other medical distribution stocks by 3 percentage points.
Cencora has an average 1 year
price target of $249.50, an upside of 11.41% from Cencora's current stock price of $223.95.
Cencora stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Cencora, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.